Hsu H Y, Chang M H, Ni Y H, Lin H H, Wang S M, Chen D S
Department of Emergency Medicine, College of Medicine, National Taiwan University, Taipei.
Hepatology. 1997 Sep;26(3):786-91. doi: 10.1002/hep.510260336.
Serum hepatitis B virus (HBV) DNA from 4 infants with fulminant hepatitis B, 3 infants with acute self-limited hepatitis B, and 15 infants with chronic HBV infection were amplified by polymerase chain reaction followed by direct sequencing of the region of HBV genome encoding the major antigenic epitopes of hepatitis B surface antigen (HBsAg). All infants were born to carrier mothers and administered immunoprophylaxis from birth. Serum HBV DNA from 13 carrier children born to carrier mothers who did not receive immunoprophylaxis and had comparable length of infection were studied as controls. An S mutant (residue 126, Thr to Ala) initially found in an infant with fulminant hepatitis was replaced by another S mutant (residue 145, Gly to Arg) 4 days later. In a girl with chronic hepatitis B, Ala-126 variant and Arg-145 variant were found at 17 and 25 months of age, respectively. The Arg-145 variant persisted for 8 years in an asymptomatic male carrier and for 1 year in an infant with chronic hepatitis B. The Ala-126 variant persisted for 11 years in one child who had an early loss of hepatitis B e antigen. In the majority of the infants' mothers, corresponding mutations in HBsAg were not detected in serum by direct sequencing. The S mutants detected in three carrier infants were not found in their mothers' serum after cloning and sequencing of 10 DNA clones from each maternal sample. None of the 13 control patients had detectable S mutants. These results suggest that S variants emerge or are selected under the immune pressure generated by the host or by administration of hepatitis B immune globulin and hepatitis B vaccination. An S mutant (residue 129, Gln to Arg) found in one mother-infant pair suggested a direct maternal-infant transmission, resulting in immunoprophylaxis failure. None of the family members of children infected with Arg-145 variant had the same variant infection, implying this variant's low transmissability.
采用聚合酶链反应扩增4例暴发性乙型肝炎婴儿、3例急性自限性乙型肝炎婴儿以及15例慢性乙型肝炎病毒(HBV)感染婴儿的血清HBV DNA,随后对HBV基因组中编码乙型肝炎表面抗原(HBsAg)主要抗原表位的区域进行直接测序。所有婴儿均为携带者母亲所生,且自出生起接受免疫预防。选取13例未接受免疫预防、感染时间相近的携带者母亲所生的携带者儿童的血清HBV DNA作为对照进行研究。最初在1例暴发性肝炎婴儿中发现的S突变体(第126位氨基酸,苏氨酸突变为丙氨酸)在4天后被另一个S突变体(第145位氨基酸,甘氨酸突变为精氨酸)取代。在1例慢性乙型肝炎女童中,分别在17个月和25个月时发现了丙氨酸-126变体和精氨酸-145变体。精氨酸-145变体在1例无症状男性携带者中持续存在8年,在1例慢性乙型肝炎婴儿中持续存在1年。丙氨酸-126变体在1例早期乙肝e抗原消失的儿童中持续存在11年。在大多数婴儿母亲的血清中,通过直接测序未检测到HBsAg的相应突变。对每个母亲样本的10个DNA克隆进行克隆和测序后,在3例携带者婴儿中检测到的S突变体未在其母亲血清中发现。13例对照患者均未检测到S突变体。这些结果表明,S变异体是在宿主产生的免疫压力或通过注射乙型肝炎免疫球蛋白和乙型肝炎疫苗的情况下出现或被选择的。在1对母婴中发现的1个S突变体(第129位氨基酸,谷氨酰胺突变为精氨酸)提示存在母婴直接传播,导致免疫预防失败。感染精氨酸-145变体的儿童的家庭成员均无相同变体感染,这意味着该变体的传播性较低。